Raffles Medical - RHB Invest 2024-07-01: Lukewarm Investor Response

• We met with investors in Kuala Lumpur to discuss the ASEAN healthcare outlook. Investors were more keen on Thailand and Indonesia healthcare stocks, and still had concerns on Singapore’s private healthcare sector and Raffles Medical (SGX:BSL).
• - Read this at SGinvestors.io -

2024 earnings growth.

• We estimate that Raffles Medical will report 13% profit growth in 2024, reversing the decline in profit witnessed in 2023. The growth will be driven by the addition of 176 more beds dedicated to the transitional care facilities (TCF) programme. This, we believe, will not only help improve its healthcare business revenue but could also boost the margin.
• - Read this at SGinvestors.io -

Near-term risks.

• Read more at SGinvestors.io.

Above is an excerpt from a report by RHB Securities Research.
Clients of RHB may be the first to access the full PDF report @ https://www.rhbtradesmart.com/.

Read also RHB's most recent report:
2026-01-23 Raffles Medical - Earnings Growth To Sustain After Returning In 2H25.

Previous report by RHB:
2025-02-25 Raffles Medical Group - Expecting Steady Improvements.

Price targets by 4 other brokers at Raffles Medical Target Prices.

Listing of research reports at Raffles Medical Analyst Reports.

Relevant links:
Raffles Medical Share Price History,
Raffles Medical Announcements,
Raffles Medical Dividend Payout Dates & Corporate Actions,
Raffles Medical News